WASHINGTON, DC, Oct. 3 – Clairus Technologies said that it is set to sign a letter of intent with an Ivy League university in the US to collaborate research on certain genomic-based diagnostic products, a company official said on Wednesday.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: genetic target for urothelial bladder cancer treatment, and more.
At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.
Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.
Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.